SV

Street Verdict

Analyst Scorecard

VIKRAMTH.BO · BSE

VIKRAM THERMO (INDIA) LTD.

₹373.25

+13.95% (+₹45.7)

Prev. close

₹327.55

Volume

0

As of

BSE · may be slightly delayed · 12:33 IST

Price history

₹327.55+₹87.25 (+36.31%) · 3M
18 Jun 2026 → 21 Sept 2026
₹356.5₹230.118 Jun13 Jul05 Aug27 Aug21 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on VIKRAM THERMO (INDIA) LTD. in the last 90 days.

Fundamentals

About VIKRAM THERMO (INDIA) LTD.

Vikram Thermo (India) Limited engages in the manufacture, marketing, and export of pharmaceutical excipients and chemicals in India and internationally. The company offers pharmaceutical polymer products, such as DRUGCOAT, a methacrylic co-polymer-based pharma polymer used for enteric and protective coating, taste masking, and sustained release formulation; DRCOAT, provides aqueous and non-aqueous based tablet coating system; and diphenyl oxide, an aromatic chemical. It also provides cosmetic polymers comprising AQUAPOL polymer, an acrylic acid polymer; and APION cross-linked polymers. The company was founded in 1985 and is based in Ahmedabad, India.

Details

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Mr. Dhirajlal Karsandas Patel B.Sc., MBA

Headquarters

Ahmedabad

Employees

153

Key stats

Market cap

₹1,027.13 Cr

P/E ratio (TTM)

23.4

Dividend yield

0.37%

EPS (TTM)

₹13.98

Beta (1Y · daily vs NIFTY 50)

0.67

Beta (5Y · monthly vs NIFTY 50)

0.72

Shares float

95.64 L

EPS · quarter ended Jun 2026

₹4.24

Financial Performance

01 · Financials

0 Cr50 Cr100 Cr150 Cr₹-20%0%20%40%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDARevenue growth YoY

Revenue for Mar 2021–Mar 2022 is as filed with BSE (standalone), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 1.1% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide.

02 · Earnings Per Share (EPS)

05101520₹FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

0112₹0%50%100%150%200%22 Sept 2023 Sept 2108 Sept 2215 Sept 2323 Sept 2419 Sept 2522 Sept 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: Yahoo (no NSE corporate-actions ledger for this listing).

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-50%-25%0%25%50%FY21FY22FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr50 Cr100 Cr150 Cr200 Cr₹0×0.25×0.5×0.75×1×FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr50 Cr100 Cr150 Cr200 Cr₹FY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

-25 Cr0 Cr25 Cr50 Cr₹FY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹73.59 Cr₹92.58 Cr₹110.38 Cr₹100.14 Cr₹124.93 Cr₹132.89 Cr
EBITDA₹18.54 Cr₹15.44 Cr₹27.32 Cr₹38.16 Cr₹47.41 Cr₹55.50 Cr
₹12.07 Cr₹8.69 Cr₹16.91 Cr₹25.38 Cr₹8.10 Cr₹38.50 Cr
Diluted EPS₹19.24₹13.86₹5.39₹8.09₹2.58₹12.28

Depreciation & amortisation, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
——₹127.21 Cr₹142.68 Cr₹145.89 Cr₹187.91 Cr
——₹18.51 Cr₹7.04 Cr₹6.40 Cr₹4.65 Cr
Stockholders' equity——₹89.68 Cr₹113.53 Cr₹121.45 Cr₹156.87 Cr

Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
——₹13.05 Cr₹23.20 Cr₹23.64 Cr₹51.58 Cr
Investing cash flow——₹-12.63 Cr₹-9.44 Cr₹-22.40 Cr₹-41.48 Cr
——₹1.49 Cr₹-14.19 Cr₹-3.96 Cr₹-5.41 Cr
Capital expenditure——₹-12.76 Cr₹-6.83 Cr₹-40.82 Cr₹-9.73 Cr
End cash position——₹3.30 Cr₹2.88 Cr₹16.17 L₹4.85 Cr

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Dividends paid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.41 L Cr₹1,868.936.55.2713.7%0.06+11.9%+12.9%
Divi's Laboratories Limited₹2.49 L Cr₹9,410.584.714.8515.3%0.00+12.3%+51.8%
Torrent Pharmaceuticals Limited₹1.84 L Cr₹4,97077.521.9525.8%1.79+21.5%+36.9%
Apollo Hospitals Enterprise Limited₹1.29 L Cr₹8,91261.713.5720.5%0.90+15.7%+14.2%
Lenskart Solutions Limited₹1.25 L Cr₹683.85188.814.295.6%0.35+35.4%—
Zydus Lifesciences Limited₹1.16 L Cr₹1,16125.84.2718.6%0.46+18.4%+11.9%
Cipla Limited₹1.13 L Cr₹1,386.133.43.2711.3%0.02+2.1%-12.0%
Laurus Labs Limited₹1.06 L Cr₹2,017.596.219.9216.8%0.48+22.0%+116.4%
Max Healthcare Institute Limited₹1.02 L Cr₹1,066.670.49.5013.4%0.32+19.0%-8.0%
Aurobindo Pharma Limited₹99,770.53 Cr₹1,713.427.12.639.2%0.21+6.4%+53.1%
Dr. Reddy's Laboratories Limited₹98,709.15 Cr₹1,198.329.82.6211.4%0.21+3.2%-9.3%
VIKRAM THERMO (INDIA) LTD.₹1,058.64 Cr₹337.624.16.7524.5%0.03+6.4%+98.3%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Annual reports

Show all 27

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

VIKRAMTH.BO

Vikram Thermo Standalone June 2026 Net Sales at Rs 37.87 crore, up 32.41% Y-o-Y

Moneycontrol.com · 1 month ago